Team – Promaxo

¹ Price, John H., et al. “Accurate Prostate Biopsies Using Low-Field Portable Intervention MRI in an Ambulatory Surgical Center.” IPCU, 2024.
² Sze, C., et al (2023). “Feasibility and preliminary clinical tolerability of low-field MRI-guided prostate biopsy.” The Prostate, 83(7), 656-662. https://doi.org/10.1002/pros.24499.
³ Sze, C., et al, (2022) “Cost-efficient analysis of a portable low field magnetic resonance imaging system for prostate cancer diagnosis.” Front. Urol.2:966862. doi: 10.3389/fruro.2022.966862.
⁴ Chiragzada, S., et al. “Advantageous Detection of Significant Prostate Cancer Using a Low-Field, Office-Based MRI System.” Cureus. 2022 Dec 1;14(12):e32105. doi:10.7759/cureus.32105. PMID: 36601170; PMCID: PMC9805358.
⁵ Data on file.
⁶ Xiang, Jianjian, et al. “Transperineal versus transrectal prostate biopsy in the diagnosis of prostate cancer: A systematic review and meta-analysis.ˮ World Journal of Surgical Oncology, vol. 17, no. 1,13 Feb. 2019, https://doi.org/10.1186/s12957-019-1573-0.
*The Promaxo Robot is not yet available for commercial sale.

We are revolutionizing healthcare with world-class leadership

Amit Vohra, PhD, MBA

President and CEO

Dinesh Kumar, PhD, MBA

Chief Operations Officer

Aleksandar Nacev, PhD

Chief Technology Officer

Srirama Venkataraman, MBA, PhD

Chief Innovation Officer

Prithipal S. Sethi, MD

Chief Medical Officer

Dan McCormick, MBA

Chief Commercial Officer

Alex Gonzalez

General Manager

Anil Dhingra

Executive VP

Ram Narayanan, PhD

Sr. VP of Product Development

Matthew Collins, MBA

VP of Global Marketing

Scott King, PhD

VP of New Product Introduction

Paul Brathwaite, PhD

VP of Project Management